phenformin has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bazelier, MT; de Vries, F; Dittrich, ST; Henry, RM; Knapen, LM; Neef, C; Starup-Linde, J; Stolk, LM; Vestergaard, P | 1 |
Alessi, DR; Din, FV; Dunlop, MG; Green, KA; Houde, VP; Sakamoto, K; Valanciute, A; Zibrova, D | 1 |
2 other study(ies) available for phenformin and Colorectal Neoplasms
Article | Year |
---|---|
Use of biguanides and the risk of colorectal cancer: a register-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biguanides; Cohort Studies; Colorectal Neoplasms; Comorbidity; Denmark; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Netherlands; Phenformin; Population; Registries; Risk Factors; Young Adult | 2013 |
Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Autophagy; Cell Cycle Proteins; Cell Line, Tumor; Colorectal Neoplasms; Female; Humans; Intestinal Mucosa; Mice; Mice, Knockout; Phenformin; Phosphoproteins; Phosphorylation; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factors | 2012 |